These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 17340669)

  • 21. Effects of the bidentate malonate ligand on the utilization and cytotoxicity of platinum compounds in the L1210 cell line.
    Mauldin SK; Husain I; Sancar A; Chaney SG
    Cancer Res; 1986 Jun; 46(6):2876-82. PubMed ID: 3698013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of amine ligands on the aquation and cytotoxicity of trans-diamine platinum(II) anticancer complexes.
    Cubo L; Quiroga AG; Zhang J; Thomas DS; Carnero A; Navarro-Ranninger C; Berners-Price SJ
    Dalton Trans; 2009 May; (18):3457-66. PubMed ID: 19381408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New antitumor-active azole-bridged dinuclear platinum(II) complexes: synthesis, characterization, crystal structures, and cytotoxic studies.
    Komeda S; Lutz M; Spek AL; Chikuma M; Reedijk J
    Inorg Chem; 2000 Sep; 39(19):4230-6. PubMed ID: 11196916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solution behaviour and biomolecular interactions of two cytotoxic trans-platinum(II) complexes bearing aliphatic amine ligands.
    Cubo L; Casini A; Gabbiani C; Mastrobuoni G; Messori L; Jiménez-Barbero J; Navarro-Ranninger C; Quiroga AG
    Chemistry; 2009 Sep; 15(36):9139-46. PubMed ID: 19655350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monofunctional platinum complexes showing potent cytotoxicity against human liver carcinoma cell line BEL-7402.
    Zhang J; Wang X; Tu C; Lin J; Ding J; Lin L; Wang Z; He C; Yan C; You X; Guo Z
    J Med Chem; 2003 Jul; 46(16):3502-7. PubMed ID: 12877588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective tumor targeting by enhanced permeability and retention effect. Synthesis and antitumor activity of polyphosphazene-platinum (II) conjugates.
    Jun YJ; Kim JI; Jun MJ; Sohn YS
    J Inorg Biochem; 2005 Aug; 99(8):1593-601. PubMed ID: 15963570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation of antitumor oxaliplatin/cisplatin docking dinuclear platinum complex.
    Noji M; Kizu R; Takeda Y; Akiyama N; Yoshizaki I; Eriguchi M; Kidani Y
    Biomed Pharmacother; 2005 Jun; 59(5):224-9. PubMed ID: 15919175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel trans-dichloridoplatinum(II) complexes with 3- and 4-acetylpyridine: Synthesis, characterization, DFT calculations and cytotoxicity.
    Rakić GM; Grgurić-Sipka S; Kaluderović GN; Gómez-Ruiz S; Bjelogrlić SK; Radulović SS; Tesić ZLj
    Eur J Med Chem; 2009 May; 44(5):1921-5. PubMed ID: 19070943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel platinum(II)-based anticancer complexes and molecular hosts as their drug delivery vehicles.
    Wheate NJ; Taleb RI; Krause-Heuer AM; Cook RL; Wang S; Higgins VJ; Aldrich-Wright JR
    Dalton Trans; 2007 Nov; (43):5055-64. PubMed ID: 17992290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platinum(II) complexes with antitumoral/antiviral aromatic heterocycles: effect of glutathione upon in vitro cell growth inhibition.
    Papadia P; Margiotta N; Bergamo A; Sava G; Natile G
    J Med Chem; 2005 May; 48(9):3364-71. PubMed ID: 15857142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation, characterization, DNA binding, and in vitro cytotoxicity of the enantiomers of the platinum(II) complexes N-methyl-, N-ethyl- and N,N-dimethyl-(R)- and -(S)-3-aminohexahydroazepinedichloroplatinum(II).
    Rezler EM; Fenton RR; Esdale WJ; McKeage MJ; Russell PJ; Hambley TW
    J Med Chem; 1997 Oct; 40(22):3508-15. PubMed ID: 9357517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes.
    Choi S; Vastag L; Larrabee YC; Personick ML; Schaberg KB; Fowler BJ; Sandwick RK; Rawji G
    Inorg Chem; 2008 Feb; 47(4):1352-60. PubMed ID: 18220340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, X-ray crystal structures and biomimetic and anticancer activities of novel copper(II)benzoate complexes incorporating 2-(4'-thiazolyl)benzimidazole (thiabendazole), 2-(2-pyridyl)benzimidazole and 1,10-phenanthroline as chelating nitrogen donor ligands.
    Devereux M; O Shea D; Kellett A; McCann M; Walsh M; Egan D; Deegan C; Kedziora K; Rosair G; Müller-Bunz H
    J Inorg Biochem; 2007 Jun; 101(6):881-92. PubMed ID: 17397929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and characterisation of mixed ligand Pt(II) and Pt(IV) oxadiazoline complexes.
    Sarju J; Arbour J; Sayer J; Rohrmoser B; Scherer W; Wagner G
    Dalton Trans; 2008 Oct; (39):5302-12. PubMed ID: 18827937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel platinum(II) and palladium(II) complexes with cyclin-dependent kinase inhibitors: synthesis, characterization and antitumour activity.
    Szucová L; Trávnícek Z; Zatloukal M; Popa I
    Bioorg Med Chem; 2006 Jan; 14(2):479-91. PubMed ID: 16198575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo antitumor activity of platinum(II) complexes with thiosemicarbazones derived from 2-formyl and 2-acetyl pyridine and containing ring incorporated at N(4)-position: synthesis, spectroscopic study and crystal structure of platinum(II) complexes with thiosemicarbazones, potential anticancer agents.
    Kovala-Demertzi D; Papageorgiou A; Papathanasis L; Alexandratos A; Dalezis P; Miller JR; Demertzis MA
    Eur J Med Chem; 2009 Mar; 44(3):1296-302. PubMed ID: 18848372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticancer activity of a series of platinum complexes integrating demethylcantharidin with isomers of 1,2-diaminocyclohexane.
    Yu CW; Li KK; Pang SK; Au-Yeung SC; Ho YP
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1686-91. PubMed ID: 16386904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New synthetic route to [bis-1,2-(aminomethyl)benzene]dichloroplatinum(II) complexes, screening for cytotoxic activity in cisplatin-sensitive and resistant human cancer cell lines, and reaction with glutathione.
    Rinke K; Grünert R; Bednarski PJ
    Pharmazie; 2001 Oct; 56(10):763-9. PubMed ID: 11683118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, in vitro cytotoxic and antiviral activity of cis-[Pt(R(-) and S(+)-2-alpha-hydroxybenzylbenzimidazole)2Cl2] complexes.
    Gökçe M; Utku S; Gür S; Ozkul A; Gümüş F
    Eur J Med Chem; 2005 Feb; 40(2):135-41. PubMed ID: 15694648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversion of structure-activity relationships of antitumor platinum complexes by acetoxime but not hydroxylamine ligands.
    Zorbas-Seifried S; Jakupec MA; Kukushkin NV; Groessl M; Hartinger CG; Semenova O; Zorbas H; Kukushkin VY; Keppler BK
    Mol Pharmacol; 2007 Jan; 71(1):357-65. PubMed ID: 17050805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.